BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cullen M, Wong-Lin K. Integrated dopaminergic neuronal model with reduced intracellular processes and inhibitory autoreceptors. IET Syst Biol 2015;9:245-58. [PMID: 26577159 DOI: 10.1049/iet-syb.2015.0018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Muddapu VR, Vijayakumar K, Ramakrishnan K, Chakravarthy VS. A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease. Front Neurosci 2022;16:797127. [DOI: 10.3389/fnins.2022.797127] [Reference Citation Analysis]
2 Nygaard G, Szigetvari PD, Grindheim AK, Ruoff P, Martinez A, Haavik J, Kleppe R, Flydal MI. Personalized Medicine to Improve Treatment of Dopa-Responsive Dystonia-A Focus on Tyrosine Hydroxylase Deficiency. J Pers Med 2021;11:1186. [PMID: 34834538 DOI: 10.3390/jpm11111186] [Reference Citation Analysis]
3 Kleppe R, Waheed Q, Ruoff P. DOPA Homeostasis by Dopamine: A Control-Theoretic View. Int J Mol Sci 2021;22:12862. [PMID: 34884667 DOI: 10.3390/ijms222312862] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Muddapu VR, Chakravarthy VS. Influence of energy deficiency on the subcellular processes of Substantia Nigra Pars Compacta cell for understanding Parkinsonian neurodegeneration. Sci Rep 2021;11:1754. [PMID: 33462293 DOI: 10.1038/s41598-021-81185-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Muddapu VR, Mandali A, Chakravarthy VS, Ramaswamy S. A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity. Front Neural Circuits 2019;13:11. [PMID: 30858799 DOI: 10.3389/fncir.2019.00011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
6 Joshi A, Wang DH, Watterson S, McClean PL, Behera CK, Sharp T, Wong-Lin K. Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease. Neuropharmacology 2020;174:108118. [PMID: 32380022 DOI: 10.1016/j.neuropharm.2020.108118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wong-Lin K, Wang DH, Moustafa AA, Cohen JY, Nakamura K. Toward a multiscale modeling framework for understanding serotonergic function. J Psychopharmacol 2017;31:1121-36. [PMID: 28417684 DOI: 10.1177/0269881117699612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]